Form 4: Sabra Health Care REIT Director Michael Foster Receives Equity Grant

Sabra Health Care REIT, Inc. Director Michael J. Foster reported the acquisition of 8,178 restricted stock units as part of the company's 2009 Performance Incentive Plan.

Summary

• Michael J. Foster, a Director of Sabra Health Care REIT, Inc. (SBRA), reported a change in beneficial ownership via an SEC Form 4 filing.
• On June 12, 2025, Mr. Foster acquired 8,178 shares of Common Stock through a grant of restricted stock units (RSUs).
• These RSUs were granted under the Issuer's 2009 Performance Incentive Plan at a price of $0 per unit, indicating a compensation grant.
• The RSUs are scheduled to vest in equal monthly installments beginning July 12, 2025, and concluding on the earlier of June 12, 2026, or the day before the next annual stockholders' meeting.
• Following this transaction, Mr. Foster directly beneficially owns 73,817 shares of Common Stock, which includes the 8,178 unvested RSUs and 43,619 stock units that have vested but the payment of which has been deferred.
• Additionally, Mr. Foster indirectly owns 42,411.745 shares through a 401(k) Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation event (RSU grant) for a director, which is generally seen as a positive for aligning interests, but it doesn't indicate any significant operational or financial news.

Positives

• The grant of restricted stock units aligns the director's interests with long-term shareholder value through increased equity ownership.
• The vesting schedule provides an incentive for continued service and performance from the director.

Negatives

• No specific negative aspects were identified in this routine insider transaction filing.

Risks

• No new specific risks were identified in this filing; it primarily reports a change in insider ownership as part of compensation.

Future Outlook

The 8,178 restricted stock units granted to Director Michael J. Foster are scheduled to vest in equal monthly installments beginning July 12, 2025, and concluding on the earlier of June 12, 2026, or the day before the next annual stockholders' meeting.

Industry Context

This Form 4 filing is a routine disclosure of an equity grant to a director, common across all industries, including the healthcare REIT sector, as part of executive and director compensation packages designed to align interests with shareholders.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a standard practice in corporate compensation across various industries, including healthcare REITs, and is consistent with common governance practices aimed at incentivizing long-term performance and retention.
• Specific comparable companies or projects are not detailed in this filing, as it focuses solely on an individual's ownership change.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of equity to a director aims to align their interests with shareholders, potentially fostering long-term value creation.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The restricted stock units granted to Director Michael J. Foster will begin vesting in equal monthly installments starting July 12, 2025.
• The vesting will continue until the earlier of June 12, 2026, or the day before the next annual stockholders' meeting.

Key Dates

Recommendation

Keywords

Sabra Health Care REIT, SBRA, Form 4, Insider Trading, Restricted Stock Units, Equity Grant, Director Compensation, Beneficial Ownership, SEC Filing